The present invention relates to a composition comprising an immunostimulant and a combination of two or more Mycobacterium tuberculosis antigens, wherein the combination comprises an antigen having a sequence having at least 90% identity to Rv3478 (SEQ ID NO: 41) and an antigen having a sequence having at least 90% identity to Rv3619 (SEQ ID NO: 46).